SONYA ALYEA: Open Payments
NPI 1023203734 · SOMERSWORTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 55 payments from 16 companies in 2025. Trend: 2023 $1,563 · 2024 $1,187 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 6 | $306 |
| ABBVIE INC. | 19 | $260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| GENZYME CORPORATION | 2 | $102 |
| Janssen Biotech, Inc. | 5 | $86 |
| Ardelyx, Inc. | 2 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Lilly USA, LLC | 2 | $56 |
| QOL Medical, LLC | 2 | $54 |
| Madrigal Pharmaceuticals | 1 | $45 |
Products named: VOQUEZNA, DUPIXENT, ENTYVIO, TREMFYA, CREON, RINVOQ, IBSRELA, XIFAXAN.
Industry payments across NH — which companies pay providers there.
